Literature DB >> 9138574

Inhibition of cross-bridge binding to actin by caldesmon fragments in skinned skeletal muscle fibers.

J F Heubach1, R Hartwell, M Ledwon, T Kraft, B Brenner, J M Chalovich.   

Abstract

Several regions within the 35-kDa COOH-terminal portion of caldesmon have been implicated in the ability of caldesmon to inhibit actin-activated myosin ATPase activity. To further define the functional regions of caldesmon, we have studied the effects of three chymotryptic fragments, one fragment produced by CNBr digestion and two fragments produced by digestion with submaxillaris arginase C protease, on the relaxed stiffness and active force of rabbit psoas fibers. Each of the regions of caldesmon studied had either direct or indirect effects on single-fiber mechanics. The 35-kDa and 20-kDa fragments of caldesmon, like intact caldesmon, were effective inhibitors of fiber stiffness, a measure of cross-bridge attachment. The 7.3-kDa and 10-kDa fragments, which constitute the NH2 and COOH halves of the 20-kDa fragment, inhibited both relaxed fiber stiffness and active force production, but with a reduced efficacy compared to the 20-kDa fragment. These results suggest that several regions within the 35-kDa COOH-terminal region of caldesmon are required for optimum function of caldesmon and that function includes inhibition of weak cross-bridge attachment and force production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9138574      PMCID: PMC1184511          DOI: 10.1016/S0006-3495(97)78775-7

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  58 in total

1.  Separation of subfragment-1 isoenzymes from rabbit skeletal muscle myosin.

Authors:  A G Weeds; R S Taylor
Journal:  Nature       Date:  1975-09-04       Impact factor: 49.962

2.  Structural and functional relationships between h- and l-caldesmons.

Authors:  K Hayashi; Y Fujio; I Kato; K Sobue
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

3.  Troponin-tropomyosin complex. Column chromatographic separation and activity of the three, active troponin components with and without tropomyosin present.

Authors:  E Eisenberg; W W Kielley
Journal:  J Biol Chem       Date:  1974-08-10       Impact factor: 5.157

4.  Purification and properties of Ca2+-regulated thin filaments and F-actin from sheep aorta smooth muscle.

Authors:  S B Marston; C W Smith
Journal:  J Muscle Res Cell Motil       Date:  1984-10       Impact factor: 2.698

5.  Inhibition of actomyosin ATPase activity by troponin-tropomyosin without blocking the binding of myosin to actin.

Authors:  J M Chalovich; E Eisenberg
Journal:  J Biol Chem       Date:  1982-03-10       Impact factor: 5.157

6.  Evidence for cross-bridge attachment in relaxed muscle at low ionic strength.

Authors:  B Brenner; M Schoenberg; J M Chalovich; L E Greene; E Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Technique for stabilizing the striation pattern in maximally calcium-activated skinned rabbit psoas fibers.

Authors:  B Brenner
Journal:  Biophys J       Date:  1983-01       Impact factor: 4.033

8.  Localization of the calmodulin- and the actin-binding sites of caldesmon.

Authors:  C L Wang; L W Wang; S A Xu; R C Lu; V Saavedra-Alanis; J Bryan
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

9.  Caldesmon is a Ca2+-regulatory component of native smooth-muscle thin filaments.

Authors:  S B Marston; W Lehman
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

10.  The influence of caldesmon on ATPase activity of the skeletal muscle actomyosin and bundling of actin filaments.

Authors:  R Dabrowska; A Goch; B Gałazkiewicz; H Osińska
Journal:  Biochim Biophys Acta       Date:  1985-09-27
View more
  1 in total

1.  Influence of age, sex, and strength training on human muscle gene expression determined by microarray.

Authors:  Stephen M Roth; Robert E Ferrell; David G Peters; E Jeffrey Metter; Ben F Hurley; Marc A Rogers
Journal:  Physiol Genomics       Date:  2002-09-03       Impact factor: 3.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.